User profiles for "author:G. Rennert"
Gad Rennertcarmel medical center, technion, clalit, haifa, israel Verified email at tx.technion.ac.il Cited by 29611 |
Global implementation of genomic medicine: we are not alone
Around the world, innovative genomic-medicine programs capitalize on singular capabilities
arising from local health care systems, cultural or political milieus, and unusual selected risk …
arising from local health care systems, cultural or political milieus, and unusual selected risk …
Beyond aspirin—cancer prevention with statins, metformin and bisphosphonates
N Gronich, G Rennert - Nature reviews Clinical oncology, 2013 - nature.com
Cancer risk reduction using pharmacological means is an attractive modern preventive
approach that supplements the classical behavioural prevention recommendations …
approach that supplements the classical behavioural prevention recommendations …
Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21
In a genome-wide association study to identify loci associated with colorectal cancer (CRC)
risk, we genotyped 555,510 SNPs in 1,012 early-onset Scottish CRC cases and 1,012 …
risk, we genotyped 555,510 SNPs in 1,012 early-onset Scottish CRC cases and 1,012 …
[HTML][HTML] Statins and the risk of colorectal cancer
Background Statins are inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase and
effective lipid-lowering agents. Statins inhibit the growth of colon-cancer cell lines, and …
effective lipid-lowering agents. Statins inhibit the growth of colon-cancer cell lines, and …
Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes
Although several lung cancer susceptibility loci have been identified, much of the heritability
for lung cancer remains unexplained. Here 14,803 cases and 12,262 controls of European …
for lung cancer remains unexplained. Here 14,803 cases and 12,262 controls of European …
Network modeling links breast cancer susceptibility and centrosome dysfunction
…, KN Stevens, M Tewari, JS Ahn, G Rennert… - Nature …, 2007 - nature.com
Many cancer-associated genes remain to be identified to clarify the underlying molecular
mechanisms of cancer susceptibility and progression. Better understanding is also required …
mechanisms of cancer susceptibility and progression. Better understanding is also required …
Discovery of common and rare genetic risk variants for colorectal cancer
To further dissect the genetic architecture of colorectal cancer (CRC), we performed whole-
genome sequencing of 1,439 cases and 720 controls, imputed discovered sequence …
genome sequencing of 1,439 cases and 720 controls, imputed discovered sequence …
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general …
Germline BRCA1 mutations predispose to breast cancer. To identify genetic modifiers of this
risk, we performed a genome-wide association study in 1,193 individuals with BRCA1 …
risk, we performed a genome-wide association study in 1,193 individuals with BRCA1 …
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
…, R Gershoni-Baruch, G Rennert… - Journal of the …, 2002 - academic.oup.com
Background: Oral contraceptive use has been associated with an increase in the risk of
breast cancer in young women. We examined whether this association is seen in women at …
breast cancer in young women. We examined whether this association is seen in women at …
[PDF][PDF] Breast Cancer Risk Following Bilateral Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: An International Case-Control Study
…, R Gershoni-Baruch, E Friedman, G Rennert… - Journal of clinical …, 2005 - seom.org
Purpose The purpose of this study was to estimate the extent of protection offered against
breast cancer by prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations and …
breast cancer by prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations and …